The 2023 American College of Rheumatology and European League Against Rheumatism antiphospholipid syndrome criteria: through the eyes of Dermatologists.

The 2023 American College of Rheumatology and European League Against Rheumatism (ACR/EULAR) antiphospholipid syndrome (APS) criteria represent a significant stride forward in the holistic understanding of APS, emphasizing the role of interdisciplinary approaches in the management of this complex autoimmune condition. For dermatologists, these criteria reinforce the importance of recognizing cutaneous manifestations as integral components of the APS management framework. By bridging the gap between dermatologic and systemic observations, dermatologists can play a pivotal role in the early detection and management of APS, ultimately contributing to improved patient outcomes. As the field progresses, continued collaboration between dermatology and rheumatology will be essential in refining classification criteria and enhancing the quality of care for patients with APS.